Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) EBT Margin (2016 - 2025)

Utah Medical Products has reported EBT Margin over the past 16 years, most recently at 96.11% for Q4 2025.

  • Quarterly results put EBT Margin at 96.11% for Q4 2025, down 9740.0% from a year ago — trailing twelve months through Dec 2025 was 6.0% (down 2653.0% YoY), and the annual figure for FY2025 was 6.0%, down 2653.0%.
  • EBT Margin for Q4 2025 was 96.11% at Utah Medical Products, down from 33.72% in the prior quarter.
  • Over the last five years, EBT Margin for UTMD hit a ceiling of 42.31% in Q1 2024 and a floor of 96.11% in Q4 2025.
  • Median EBT Margin over the past 5 years was 38.41% (2021), compared with a mean of 20.45%.
  • Biggest five-year swings in EBT Margin: soared 5118bps in 2024 and later crashed -9740bps in 2025.
  • Utah Medical Products' EBT Margin stood at 14.53% in 2021, then plummeted by -31bps to 19.1% in 2022, then plummeted by -161bps to 49.89% in 2023, then surged by 103bps to 1.29% in 2024, then crashed by -7558bps to 96.11% in 2025.
  • The last three reported values for EBT Margin were 96.11% (Q4 2025), 33.72% (Q3 2025), and 38.54% (Q2 2025) per Business Quant data.